Last reviewed · How we verify

Rohto (r) Hydra — Competitive Intelligence Brief

Rohto (r) Hydra (Rohto (r) Hydra) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Ophthalmic lubricant / Artificial tear. Area: Ophthalmology.

marketed Ophthalmic lubricant / Artificial tear Ophthalmology Small molecule Live · refreshed every 30 min

Target snapshot

Rohto (r) Hydra (Rohto (r) Hydra) — ORA, Inc.. Rohto Hydra is an ophthalmic lubricant that provides moisture and relief to dry eyes by forming a protective hydrating layer on the ocular surface.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Rohto (r) Hydra TARGET Rohto (r) Hydra ORA, Inc. marketed Ophthalmic lubricant / Artificial tear
Systane PRO Systane PRO Scripps Poway Eyecare and Optometry marketed Ophthalmic lubricant / artificial tear
Refresh Endura Refresh Endura Federal University of São Paulo marketed Ophthalmic lubricant / Artificial tear

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Ophthalmic lubricant / Artificial tear class)

  1. Federal University of São Paulo · 1 drug in this class
  2. ORA, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Rohto (r) Hydra — Competitive Intelligence Brief. https://druglandscape.com/ci/rohto-r-hydra. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: